Today’s post first ran on Health Populi on July 24.
The high cost of specialty drugs, opaque information on risks of many existing prescription drugs, and lack of cures for diseases impacting millions of people are forces driving patients into activism, the likes of which we haven’t seen since the emergence of AIDS.
I was reminded this yesterday, not inside the Beltway at an FDA or Congressional hearing, or in an online social network of patient activists.
I was visiting the newly re-opened and re-built Whitney Museum, an architectural gem now re-energizing the Meatpacking District in Lower Manhattan.
It wasn’t the building design (which is getting rave reviews from architecture critics) that turned my mind toward a déjà vu on health politics, but in the Neil Bluhm Family Galleries on the 5th floor which features artworks created during the AIDS crisis beginning in the early 1980s. (more…)